These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19171932)

  • 21. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.
    Vilchez D; Ros S; Cifuentes D; Pujadas L; Vallès J; García-Fojeda B; Criado-García O; Fernández-Sánchez E; Medraño-Fernández I; Domínguez J; García-Rocha M; Soriano E; Rodríguez de Córdoba S; Guinovart JJ
    Nat Neurosci; 2007 Nov; 10(11):1407-13. PubMed ID: 17952067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.
    Singh PK; Singh S; Ganesh S
    Mol Cell Biol; 2012 Feb; 32(3):652-63. PubMed ID: 22124153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential pattern of glycogen accumulation after protein phosphatase 1 glycogen-targeting subunit PPP1R6 overexpression, compared to PPP1R3C and PPP1R3A, in skeletal muscle cells.
    Montori-Grau M; Guitart M; García-Martínez C; Orozco A; Gómez-Foix AM
    BMC Biochem; 2011 Nov; 12():57. PubMed ID: 22054094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.
    Rao SN; Sharma J; Maity R; Jana NR
    J Biol Chem; 2010 Jan; 285(2):1404-13. PubMed ID: 19892702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
    Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
    Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A PTG variant contributes to a milder phenotype in Lafora disease.
    Guerrero R; Vernia S; Sanz R; Abreu-Rodríguez I; Almaraz C; García-Hoyos M; Michelucci R; Tassinari CA; Riguzzi P; Nobile C; Sanz P; Serratosa JM; Gómez-Garre P
    PLoS One; 2011; 6(6):e21294. PubMed ID: 21738631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.
    Garyali P; Siwach P; Singh PK; Puri R; Mittal S; Sengupta S; Parihar R; Ganesh S
    Hum Mol Genet; 2009 Feb; 18(4):688-700. PubMed ID: 19036738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of binding sites on protein targeting to glycogen for enzymes of glycogen metabolism.
    Fong NM; Jensen TC; Shah AS; Parekh NN; Saltiel AR; Brady MJ
    J Biol Chem; 2000 Nov; 275(45):35034-9. PubMed ID: 10938087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epinephrine control of glycogen metabolism in glycogen-associated protein phosphatase PP1G/R(GL) knockout mice.
    Kim JH; DePaoli-Roach AA
    J Biochem Mol Biol; 2002 May; 35(3):283-90. PubMed ID: 12297011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, GL, GM/RGl) expressed in hepatocytes.
    Gasa R; Jensen PB; Berman HK; Brady MJ; DePaoli-Roach AA; Newgard CB
    J Biol Chem; 2000 Aug; 275(34):26396-403. PubMed ID: 10862764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-stimulated phosphorylation of the protein phosphatase-1 striated muscle glycogen-targeting subunit and activation of glycogen synthase.
    Liu J; Brautigan DL
    J Biol Chem; 2000 May; 275(21):15940-7. PubMed ID: 10748124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
    Gentry MS; Worby CA; Dixon JE
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The regulation of muscle glycogen: the granule and its proteins.
    Graham TE; Yuan Z; Hill AK; Wilson RJ
    Acta Physiol (Oxf); 2010 Aug; 199(4):489-98. PubMed ID: 20353490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of malin, but not laforin, results in compromised autophagic flux and proteasomal dysfunction in cells exposed to heat shock.
    Jain N; Rai A; Mishra R; Ganesh S
    Cell Stress Chaperones; 2017 Mar; 22(2):307-315. PubMed ID: 27975203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
    Mittal S; Dubey D; Yamakawa K; Ganesh S
    Hum Mol Genet; 2007 Apr; 16(7):753-62. PubMed ID: 17337485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTG protein depletion rescues malin-deficient Lafora disease in mouse.
    Turnbull J; Epp JR; Goldsmith D; Zhao X; Pencea N; Wang P; Frankland PW; Ackerley CA; Minassian BA
    Ann Neurol; 2014 Mar; 75(3):442-6. PubMed ID: 24419970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 5'AMP-activated protein kinase in glycogen synthase activity and glucose utilization: insights from patients with McArdle's disease.
    Nielsen JN; Wojtaszewski JF; Haller RG; Hardie DG; Kemp BE; Richter EA; Vissing J
    J Physiol; 2002 Jun; 541(Pt 3):979-89. PubMed ID: 12068056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.